Contents
Academy · Research Data, Analytics & AI · Use of clinical practice guidelines
The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement
The trustworthiness of a clinical practice guideline depends on the process by which it was developed. The Institute of Medicine (IOM) criteria exist because that process can fail in ways that a confidently worded recommendation does not itself reveal.
A clinical practice guideline is a document offering recommendations for clinical care, developed through a systematic review of the evidence and a structured assessment of the benefits and harms of alternative care options, and intended to support, not replace, clinical decision-making for a specific condition or population.
Learning objectives
- The criteria defined by the Institute of Medicine for a trustworthy clinical practice guideline.
- Why a systematic review of the evidence base is a required input rather than an optional step.
- The meaning of recommendation strength and certainty of evidence in a guideline, and why they are reported separately.
- Why guidelines should inform, rather than mechanically determine, individual clinical decisions.
Common misconceptions
- “Any expert consensus document constitutes a clinical practice guideline.” The Institute of Medicine's standards for trustworthy guidelines require a systematic review of the evidence as a defined input, explicit management of developer conflicts of interest, and external review; a consensus statement lacking these elements does not meet the same standard.
- “A guideline recommendation applies identically to every patient with the diagnosis.” Guidelines are explicitly intended to inform clinical judgement for a typical patient in the population studied, not to override judgement for an individual patient whose circumstances differ from that population.
Criteria for a trustworthy guideline
The U.S. Institute of Medicine's influential report, Clinical Practice Guidelines We Can Trust, sets out explicit standards that a guideline development process should meet to be considered trustworthy: a systematic review of the evidence underlying each recommendation, a multidisciplinary development group including patient and public representation, explicit disclosure and management of financial and intellectual conflicts of interest, external review before publication, and a plan for updating the guideline as new evidence emerges. A document described as a guideline that omits these steps, for example a recommendation based on informal expert consensus without a systematic evidence review, does not meet the standard that the report defines.
Recommendation strength and certainty of evidence
A rigorously developed guideline reports two related but distinct judgements for each recommendation: the strength of the recommendation (the confidence of the development group that the benefits outweigh the harms, or vice versa) and the certainty of the underlying evidence (the confidence of the group that further research would not change the effect estimate). The IOM standards require both to be stated, because a strong recommendation can rest on low-certainty evidence when the balance of plausible benefit and harm is judged to be clear despite that uncertainty, and the two items of information serve different purposes for a clinician deciding whether, and how firmly, to follow the recommendation.
The role of guidelines in informing clinical judgement
The IOM report presents guidelines as tools intended to inform clinical decision-making for a population typical of the one studied, and explicitly not as a mechanical substitute for an individual clinician's judgement about a specific patient whose circumstances, comorbidities or preferences diverge from that typical population. Appropriate use of a guideline therefore involves applying its recommendation as a well-evidenced starting point, adjusted where the individual case genuinely differs, rather than following it uniformly irrespective of fit.
Key points
Key points
According to the Institute of Medicine's standards, a trustworthy clinical practice guideline rests on a systematic evidence review, managed conflicts of interest and external review, and reports recommendation strength and evidence certainty separately; it is intended to inform, not mechanically replace, a clinician's judgement about an individual patient whose circumstances may differ from the population on which the guideline was based.
Practical application
Practical application
- The development process should be examined before a guideline is relied upon. It should be confirmed that the guideline was based on a systematic evidence review, with managed conflicts of interest and external review, rather than inferring trustworthiness from the name of the issuing body alone.
- Recommendation strength and certainty of evidence should be reported separately. When a guideline recommendation is cited or applied, both the strength of the recommendation and the certainty of the underlying evidence should be noted, since these have different implications for how strictly it should be applied.
- Divergence between an individual patient’s circumstances and the guideline population should be documented. When a guideline recommendation is not followed for a specific patient, the clinical reasoning for that decision should be recorded explicitly.
Frequently asked questions
No; the quality of guideline development varies considerably, which is why the IOM set out explicit criteria. Assessing a guideline against those criteria is more informative than inferring its quality from the publishing body alone.
A strong recommendation reflects high confidence that benefits clearly outweigh harms (or vice versa) for most patients; a weak or conditional recommendation reflects a closer balance or greater uncertainty, in which case individual patient values and circumstances should carry greater weight in the decision.
A guideline can still make a strong recommendation on low-certainty evidence if the panel judges the balance of plausible benefit and harm to be clear; the IOM standard requires that the level of certainty be stated transparently, not that low-certainty evidence disqualify a recommendation.
References
- Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011. read 10 October 2026. View report on National Academies Press
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement. Pubrica. https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/
Pubrica Academy. “The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/.
Pubrica Academy (2026) The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/ (Accessed: 15 October 2026).
Pubrica Academy. “The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/
Pubrica Academy, ‘The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/> accessed 15 October 2026.
Pubrica Academy. The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/
Pubrica Academy, “The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/
@misc{use_of_clinical_practice_guidelines_2026,
author = {{Pubrica Academy}},
title = {The Use of Clinical Practice Guidelines: Trustworthiness, Recommendation Strength and Clinical Judgement},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/use-of-clinical-practice-guidelines/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Guideline trustworthiness check stub
This checklist should be used when evaluating whether to rely on a clinical practice guideline.
Guideline title and issuing body: ____ Systematic evidence review conducted? Y/N Multidisciplinary development group, incl. patient representation? Y/N Conflicts of interest disclosed and managed? Y/N External review conducted before publication? Y/N Recommendation strength stated separately from evidence certainty? Y/N Update plan stated? Y/N
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s research impact team evaluates clinical practice guidelines against the IOM trustworthiness standard before they are relied upon or cited, and supports the structuring of new guideline development to meet that standard.